Exploring 2016 Wmif Disruptive Dozen 10
Exploring 2016 Wmif Disruptive Dozen 10 reveals several interesting facts.
- Cellular Immunotherapy Introduction by: Daniel Haber, MD, PhD, Director, MGH Cancer Center, Kurt J. Isselbacher/Peter D.
- Nanotechnology and Cancer Treatment Introduction by: Monica Bertagnolli, MD, Chief, Division of Surgical Oncology, BWH, ...
- The Microbiome and Cancer Introduction by: Monica Bertagnolli, MD, Chief, Division of Surgical Oncology, BWH, Professor of ...
- New Technologies for Delivering Gene Therapies Viruses have been co-opted as delivery vehicles, shuttling therapeutic genes to ...
- Introduction by: Monica Bertagnolli, MD, Chief, Division of Surgical Oncology, BWH, Professor of Surgery, Harvard Medical School ...
In-Depth Information on 2016 Wmif Disruptive Dozen 10
Patient-Specific Research to Enable Efficient Drug Development Introduction by: Daniel Haber, MD, PhD, Director, MGH Cancer ... Redefining Value in Cancer Care Introduction by: Daniel Haber, MD, PhD, Director, MGH Cancer Center, Kurt J. Isselbacher/Peter ... 10 mHealth and Cancer Care Introduction by: Monica Bertagnolli, MD, Chief, Division of Surgical Oncology, BWH, Professor of ...
Visualizing cells at high-resolution is a cornerstone of modern biology and medicine. Over hundreds of years, as scientists ...
Stay tuned for more updates related to 2016 Wmif Disruptive Dozen 10.
